REQUEST A DEMO
Total
USD $0.00
Search more companies

Drugmarket S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Drugmarket S.R.O. Profile Updated: July 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Drugmarket S.R.O. is an enterprise based in Slovakia. Its main office is in Kosice. It operates in the Pharmacies and Drug Stores industry. The company was established on May 17, 2007. 10 - 19 (2025) employees currently work for Drugmarket S.R.O.. There was a net sales revenue increase of 11.71% reported in Drugmarket S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 19.44%. The net profit margin of Drugmarket S.R.O. increased by 0.96% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Drugmarket S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Drugmarket S.R.O. report to view the information.
Registered Capital:
Purchase the Drugmarket S.R.O. report to view the information.
Financial Auditors:
Purchase the Drugmarket S.R.O. report to view the information.
Incorporation Date:
May 17, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Drugmarket S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.71%
Total operating revenue
11.35%
Operating profit (EBIT)
88.96%
EBITDA
60.75%
Net Profit (Loss) for the Period
96.06%
Total assets
19.44%
Total equity
28.22%
Operating Profit Margin (ROS)
1.07%
Net Profit Margin
0.96%
Return on Equity (ROE)
7.61%
Debt to Equity Ratio
-0.64%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?